nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—ABCB1—melanoma	0.393	1	CbGaD
Trimethoprim—CYP3A4—Temozolomide—melanoma	0.0931	0.376	CbGbCtD
Trimethoprim—ABCB1—Dactinomycin—melanoma	0.0566	0.229	CbGbCtD
Trimethoprim—CYP3A4—Vemurafenib—melanoma	0.051	0.206	CbGbCtD
Trimethoprim—ABCB1—Docetaxel—melanoma	0.0292	0.118	CbGbCtD
Trimethoprim—CYP3A4—Docetaxel—melanoma	0.0175	0.0708	CbGbCtD
Trimethoprim—TYMS—Paclitaxel—Docetaxel—melanoma	0.00537	1	CbGdCrCtD
Trimethoprim—Aplastic anaemia—Dactinomycin—melanoma	0.00161	0.0076	CcSEcCtD
Trimethoprim—Connective tissue disorder—Vemurafenib—melanoma	0.0015	0.00707	CcSEcCtD
Trimethoprim—Aplastic anaemia—Temozolomide—melanoma	0.00146	0.00687	CcSEcCtD
Trimethoprim—Erythema multiforme—Vemurafenib—melanoma	0.00144	0.0068	CcSEcCtD
Trimethoprim—Eye disorder—Vemurafenib—melanoma	0.00143	0.00672	CcSEcCtD
Trimethoprim—Neuritis—Docetaxel—melanoma	0.00138	0.00652	CcSEcCtD
Trimethoprim—Mediastinal disorder—Vemurafenib—melanoma	0.00137	0.00648	CcSEcCtD
Trimethoprim—Erythema—Vemurafenib—melanoma	0.00133	0.00626	CcSEcCtD
Trimethoprim—Malnutrition—Vemurafenib—melanoma	0.00133	0.00626	CcSEcCtD
Trimethoprim—Lethargy—Dactinomycin—melanoma	0.00127	0.006	CcSEcCtD
Trimethoprim—Vascular purpura—Temozolomide—melanoma	0.00126	0.00594	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Temozolomide—melanoma	0.00119	0.00563	CcSEcCtD
Trimethoprim—Hyponatraemia—Carmustine—melanoma	0.00117	0.00552	CcSEcCtD
Trimethoprim—Purpura—Temozolomide—melanoma	0.00117	0.00551	CcSEcCtD
Trimethoprim—Cough—Vemurafenib—melanoma	0.00116	0.00546	CcSEcCtD
Trimethoprim—Arthralgia—Vemurafenib—melanoma	0.00113	0.00533	CcSEcCtD
Trimethoprim—Myalgia—Vemurafenib—melanoma	0.00113	0.00533	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00112	0.00529	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00112	0.00529	CcSEcCtD
Trimethoprim—Pancytopenia—Bleomycin—melanoma	0.0011	0.00517	CcSEcCtD
Trimethoprim—Ataxia—Carmustine—melanoma	0.0011	0.00517	CcSEcCtD
Trimethoprim—Anaphylactic shock—Vemurafenib—melanoma	0.00108	0.00511	CcSEcCtD
Trimethoprim—Nervous system disorder—Vemurafenib—melanoma	0.00106	0.00501	CcSEcCtD
Trimethoprim—Ataxia—Temozolomide—melanoma	0.00106	0.005	CcSEcCtD
Trimethoprim—Skin disorder—Vemurafenib—melanoma	0.00105	0.00496	CcSEcCtD
Trimethoprim—Pneumonia—Bleomycin—melanoma	0.00104	0.00488	CcSEcCtD
Trimethoprim—Pancytopenia—Dactinomycin—melanoma	0.00102	0.00482	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00101	0.00479	CcSEcCtD
Trimethoprim—Neutropenia—Dactinomycin—melanoma	0.00101	0.00475	CcSEcCtD
Trimethoprim—Stomatitis—Bleomycin—melanoma	0.001	0.00473	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000987	0.00466	CcSEcCtD
Trimethoprim—Haematuria—Bleomycin—melanoma	0.000982	0.00463	CcSEcCtD
Trimethoprim—Pneumonia—Dactinomycin—melanoma	0.000966	0.00455	CcSEcCtD
Trimethoprim—Pancytopenia—Carmustine—melanoma	0.000957	0.00451	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000952	0.00449	CcSEcCtD
Trimethoprim—Neutropenia—Carmustine—melanoma	0.000942	0.00444	CcSEcCtD
Trimethoprim—Decreased appetite—Vemurafenib—melanoma	0.000942	0.00444	CcSEcCtD
Trimethoprim—Stomatitis—Dactinomycin—melanoma	0.000936	0.00441	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Vemurafenib—melanoma	0.000936	0.00441	CcSEcCtD
Trimethoprim—Constipation—Vemurafenib—melanoma	0.000927	0.00437	CcSEcCtD
Trimethoprim—Pancytopenia—Temozolomide—melanoma	0.000925	0.00436	CcSEcCtD
Trimethoprim—Neutropenia—Temozolomide—melanoma	0.000911	0.00429	CcSEcCtD
Trimethoprim—Pneumonia—Carmustine—melanoma	0.000904	0.00426	CcSEcCtD
Trimethoprim—Depression—Carmustine—melanoma	0.000896	0.00423	CcSEcCtD
Trimethoprim—Agranulocytosis—Dactinomycin—melanoma	0.000896	0.00423	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Temozolomide—melanoma	0.000889	0.00419	CcSEcCtD
Trimethoprim—Renal failure—Carmustine—melanoma	0.000883	0.00417	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Carmustine—melanoma	0.000881	0.00415	CcSEcCtD
Trimethoprim—Stomatitis—Carmustine—melanoma	0.000876	0.00413	CcSEcCtD
Trimethoprim—Pneumonia—Temozolomide—melanoma	0.000873	0.00412	CcSEcCtD
Trimethoprim—Infestation NOS—Temozolomide—melanoma	0.000868	0.0041	CcSEcCtD
Trimethoprim—Infestation—Temozolomide—melanoma	0.000868	0.0041	CcSEcCtD
Trimethoprim—Depression—Temozolomide—melanoma	0.000866	0.00408	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000861	0.00406	CcSEcCtD
Trimethoprim—Body temperature increased—Vemurafenib—melanoma	0.000857	0.00404	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Temozolomide—melanoma	0.000851	0.00401	CcSEcCtD
Trimethoprim—Stomatitis—Temozolomide—melanoma	0.000846	0.00399	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Temozolomide—melanoma	0.000821	0.00387	CcSEcCtD
Trimethoprim—Erythema multiforme—Dactinomycin—melanoma	0.000815	0.00384	CcSEcCtD
Trimethoprim—Erythema—Bleomycin—melanoma	0.000804	0.00379	CcSEcCtD
Trimethoprim—Hallucination—Carmustine—melanoma	0.000803	0.00379	CcSEcCtD
Trimethoprim—Hypersensitivity—Vemurafenib—melanoma	0.000798	0.00377	CcSEcCtD
Trimethoprim—Connective tissue disorder—Carmustine—melanoma	0.000793	0.00374	CcSEcCtD
Trimethoprim—Renal impairment—Docetaxel—melanoma	0.000787	0.00371	CcSEcCtD
Trimethoprim—Dermatitis bullous—Docetaxel—melanoma	0.000784	0.0037	CcSEcCtD
Trimethoprim—Hallucination—Temozolomide—melanoma	0.000776	0.00366	CcSEcCtD
Trimethoprim—Urinary tract disorder—Temozolomide—melanoma	0.00077	0.00363	CcSEcCtD
Trimethoprim—Pruritus—Vemurafenib—melanoma	0.000767	0.00362	CcSEcCtD
Trimethoprim—Connective tissue disorder—Temozolomide—melanoma	0.000766	0.00361	CcSEcCtD
Trimethoprim—Lethargy—Docetaxel—melanoma	0.000765	0.00361	CcSEcCtD
Trimethoprim—Urethral disorder—Temozolomide—melanoma	0.000764	0.0036	CcSEcCtD
Trimethoprim—Eye disorder—Carmustine—melanoma	0.000754	0.00356	CcSEcCtD
Trimethoprim—Hyponatraemia—Docetaxel—melanoma	0.000752	0.00355	CcSEcCtD
Trimethoprim—Erythema—Dactinomycin—melanoma	0.00075	0.00354	CcSEcCtD
Trimethoprim—Diarrhoea—Vemurafenib—melanoma	0.000741	0.0035	CcSEcCtD
Trimethoprim—Erythema multiforme—Temozolomide—melanoma	0.000737	0.00348	CcSEcCtD
Trimethoprim—Eye disorder—Temozolomide—melanoma	0.000729	0.00344	CcSEcCtD
Trimethoprim—Tinnitus—Temozolomide—melanoma	0.000727	0.00343	CcSEcCtD
Trimethoprim—Leukopenia—Bleomycin—melanoma	0.00072	0.0034	CcSEcCtD
Trimethoprim—Dizziness—Vemurafenib—melanoma	0.000717	0.00338	CcSEcCtD
Trimethoprim—Mental disorder—Carmustine—melanoma	0.000707	0.00333	CcSEcCtD
Trimethoprim—Ataxia—Docetaxel—melanoma	0.000705	0.00332	CcSEcCtD
Trimethoprim—Immune system disorder—Temozolomide—melanoma	0.000704	0.00332	CcSEcCtD
Trimethoprim—Mediastinal disorder—Temozolomide—melanoma	0.000703	0.00331	CcSEcCtD
Trimethoprim—Erythema—Carmustine—melanoma	0.000702	0.00331	CcSEcCtD
Trimethoprim—Malnutrition—Carmustine—melanoma	0.000702	0.00331	CcSEcCtD
Trimethoprim—Cough—Bleomycin—melanoma	0.000702	0.00331	CcSEcCtD
Trimethoprim—Vomiting—Vemurafenib—melanoma	0.000689	0.00325	CcSEcCtD
Trimethoprim—Myalgia—Bleomycin—melanoma	0.000685	0.00323	CcSEcCtD
Trimethoprim—Rash—Vemurafenib—melanoma	0.000683	0.00322	CcSEcCtD
Trimethoprim—Mental disorder—Temozolomide—melanoma	0.000683	0.00322	CcSEcCtD
Trimethoprim—Dermatitis—Vemurafenib—melanoma	0.000683	0.00322	CcSEcCtD
Trimethoprim—Headache—Vemurafenib—melanoma	0.000679	0.0032	CcSEcCtD
Trimethoprim—Erythema—Temozolomide—melanoma	0.000679	0.0032	CcSEcCtD
Trimethoprim—Malnutrition—Temozolomide—melanoma	0.000679	0.0032	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000675	0.00318	CcSEcCtD
Trimethoprim—Leukopenia—Dactinomycin—melanoma	0.000672	0.00317	CcSEcCtD
Trimethoprim—Confusional state—Bleomycin—melanoma	0.000662	0.00312	CcSEcCtD
Trimethoprim—Tremor—Carmustine—melanoma	0.000658	0.0031	CcSEcCtD
Trimethoprim—Anaphylactic shock—Bleomycin—melanoma	0.000657	0.0031	CcSEcCtD
Trimethoprim—Agitation—Carmustine—melanoma	0.000645	0.00304	CcSEcCtD
Trimethoprim—Nausea—Vemurafenib—melanoma	0.000644	0.00304	CcSEcCtD
Trimethoprim—Thrombocytopenia—Bleomycin—melanoma	0.000643	0.00303	CcSEcCtD
Trimethoprim—Myalgia—Dactinomycin—melanoma	0.000639	0.00301	CcSEcCtD
Trimethoprim—Tremor—Temozolomide—melanoma	0.000636	0.003	CcSEcCtD
Trimethoprim—Leukopenia—Carmustine—melanoma	0.000629	0.00296	CcSEcCtD
Trimethoprim—Anorexia—Bleomycin—melanoma	0.000626	0.00295	CcSEcCtD
Trimethoprim—Agitation—Temozolomide—melanoma	0.000624	0.00294	CcSEcCtD
Trimethoprim—Angioedema—Temozolomide—melanoma	0.00062	0.00292	CcSEcCtD
Trimethoprim—Pancytopenia—Docetaxel—melanoma	0.000615	0.0029	CcSEcCtD
Trimethoprim—Vertigo—Temozolomide—melanoma	0.00061	0.00288	CcSEcCtD
Trimethoprim—Convulsion—Carmustine—melanoma	0.000608	0.00287	CcSEcCtD
Trimethoprim—Leukopenia—Temozolomide—melanoma	0.000607	0.00286	CcSEcCtD
Trimethoprim—Neutropenia—Docetaxel—melanoma	0.000606	0.00286	CcSEcCtD
Trimethoprim—Thrombocytopenia—Dactinomycin—melanoma	0.0006	0.00283	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Bleomycin—melanoma	0.000598	0.00282	CcSEcCtD
Trimethoprim—Myalgia—Carmustine—melanoma	0.000598	0.00282	CcSEcCtD
Trimethoprim—Anxiety—Carmustine—melanoma	0.000596	0.00281	CcSEcCtD
Trimethoprim—Cough—Temozolomide—melanoma	0.000592	0.00279	CcSEcCtD
Trimethoprim—Convulsion—Temozolomide—melanoma	0.000588	0.00277	CcSEcCtD
Trimethoprim—Dyspnoea—Bleomycin—melanoma	0.000585	0.00276	CcSEcCtD
Trimethoprim—Anorexia—Dactinomycin—melanoma	0.000584	0.00275	CcSEcCtD
Trimethoprim—Pneumonia—Docetaxel—melanoma	0.000581	0.00274	CcSEcCtD
Trimethoprim—Confusional state—Carmustine—melanoma	0.000578	0.00273	CcSEcCtD
Trimethoprim—Myalgia—Temozolomide—melanoma	0.000578	0.00272	CcSEcCtD
Trimethoprim—Arthralgia—Temozolomide—melanoma	0.000578	0.00272	CcSEcCtD
Trimethoprim—Infestation NOS—Docetaxel—melanoma	0.000577	0.00272	CcSEcCtD
Trimethoprim—Infestation—Docetaxel—melanoma	0.000577	0.00272	CcSEcCtD
Trimethoprim—Anxiety—Temozolomide—melanoma	0.000576	0.00272	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000574	0.00271	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000573	0.0027	CcSEcCtD
Trimethoprim—Decreased appetite—Bleomycin—melanoma	0.000571	0.00269	CcSEcCtD
Trimethoprim—Renal failure—Docetaxel—melanoma	0.000568	0.00268	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Docetaxel—melanoma	0.000566	0.00267	CcSEcCtD
Trimethoprim—Stomatitis—Docetaxel—melanoma	0.000563	0.00265	CcSEcCtD
Trimethoprim—Thrombocytopenia—Carmustine—melanoma	0.000561	0.00265	CcSEcCtD
Trimethoprim—Confusional state—Temozolomide—melanoma	0.000558	0.00263	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000558	0.00263	CcSEcCtD
Trimethoprim—Anaphylactic shock—Temozolomide—melanoma	0.000554	0.00261	CcSEcCtD
Trimethoprim—Anorexia—Carmustine—melanoma	0.000546	0.00258	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Docetaxel—melanoma	0.000546	0.00258	CcSEcCtD
Trimethoprim—Epistaxis—Docetaxel—melanoma	0.000545	0.00257	CcSEcCtD
Trimethoprim—Nervous system disorder—Temozolomide—melanoma	0.000543	0.00256	CcSEcCtD
Trimethoprim—Thrombocytopenia—Temozolomide—melanoma	0.000542	0.00256	CcSEcCtD
Trimethoprim—Feeling abnormal—Bleomycin—melanoma	0.000541	0.00255	CcSEcCtD
Trimethoprim—Agranulocytosis—Docetaxel—melanoma	0.000539	0.00254	CcSEcCtD
Trimethoprim—Skin disorder—Temozolomide—melanoma	0.000538	0.00254	CcSEcCtD
Trimethoprim—Decreased appetite—Dactinomycin—melanoma	0.000532	0.00251	CcSEcCtD
Trimethoprim—Anorexia—Temozolomide—melanoma	0.000528	0.00249	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Carmustine—melanoma	0.000522	0.00246	CcSEcCtD
Trimethoprim—Urticaria—Bleomycin—melanoma	0.000522	0.00246	CcSEcCtD
Trimethoprim—Body temperature increased—Bleomycin—melanoma	0.000519	0.00245	CcSEcCtD
Trimethoprim—Insomnia—Carmustine—melanoma	0.000518	0.00244	CcSEcCtD
Trimethoprim—Urinary tract disorder—Docetaxel—melanoma	0.000512	0.00241	CcSEcCtD
Trimethoprim—Dyspnoea—Carmustine—melanoma	0.000511	0.00241	CcSEcCtD
Trimethoprim—Connective tissue disorder—Docetaxel—melanoma	0.000509	0.0024	CcSEcCtD
Trimethoprim—Urethral disorder—Docetaxel—melanoma	0.000508	0.0024	CcSEcCtD
Trimethoprim—Feeling abnormal—Dactinomycin—melanoma	0.000505	0.00238	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Temozolomide—melanoma	0.000505	0.00238	CcSEcCtD
Trimethoprim—Insomnia—Temozolomide—melanoma	0.000501	0.00236	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Dactinomycin—melanoma	0.000501	0.00236	CcSEcCtD
Trimethoprim—Decreased appetite—Carmustine—melanoma	0.000498	0.00235	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Carmustine—melanoma	0.000495	0.00233	CcSEcCtD
Trimethoprim—Dyspnoea—Temozolomide—melanoma	0.000494	0.00233	CcSEcCtD
Trimethoprim—Erythema multiforme—Docetaxel—melanoma	0.00049	0.00231	CcSEcCtD
Trimethoprim—Constipation—Carmustine—melanoma	0.00049	0.00231	CcSEcCtD
Trimethoprim—Dyspepsia—Temozolomide—melanoma	0.000488	0.0023	CcSEcCtD
Trimethoprim—Eye disorder—Docetaxel—melanoma	0.000484	0.00228	CcSEcCtD
Trimethoprim—Abdominal pain—Dactinomycin—melanoma	0.000484	0.00228	CcSEcCtD
Trimethoprim—Body temperature increased—Dactinomycin—melanoma	0.000484	0.00228	CcSEcCtD
Trimethoprim—Hypersensitivity—Bleomycin—melanoma	0.000484	0.00228	CcSEcCtD
Trimethoprim—Decreased appetite—Temozolomide—melanoma	0.000481	0.00227	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Temozolomide—melanoma	0.000478	0.00225	CcSEcCtD
Trimethoprim—Constipation—Temozolomide—melanoma	0.000474	0.00223	CcSEcCtD
Trimethoprim—Feeling abnormal—Carmustine—melanoma	0.000472	0.00223	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Carmustine—melanoma	0.000469	0.00221	CcSEcCtD
Trimethoprim—Immune system disorder—Docetaxel—melanoma	0.000468	0.00221	CcSEcCtD
Trimethoprim—Mediastinal disorder—Docetaxel—melanoma	0.000467	0.0022	CcSEcCtD
Trimethoprim—Pruritus—Bleomycin—melanoma	0.000465	0.00219	CcSEcCtD
Trimethoprim—Feeling abnormal—Temozolomide—melanoma	0.000456	0.00215	CcSEcCtD
Trimethoprim—Mental disorder—Docetaxel—melanoma	0.000454	0.00214	CcSEcCtD
Trimethoprim—Abdominal pain—Carmustine—melanoma	0.000453	0.00214	CcSEcCtD
Trimethoprim—Body temperature increased—Carmustine—melanoma	0.000453	0.00214	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Temozolomide—melanoma	0.000453	0.00214	CcSEcCtD
Trimethoprim—Erythema—Docetaxel—melanoma	0.000451	0.00213	CcSEcCtD
Trimethoprim—Malnutrition—Docetaxel—melanoma	0.000451	0.00213	CcSEcCtD
Trimethoprim—Hypersensitivity—Dactinomycin—melanoma	0.000451	0.00213	CcSEcCtD
Trimethoprim—Urticaria—Temozolomide—melanoma	0.00044	0.00207	CcSEcCtD
Trimethoprim—Abdominal pain—Temozolomide—melanoma	0.000438	0.00206	CcSEcCtD
Trimethoprim—Body temperature increased—Temozolomide—melanoma	0.000438	0.00206	CcSEcCtD
Trimethoprim—Hypersensitivity—Carmustine—melanoma	0.000422	0.00199	CcSEcCtD
Trimethoprim—Diarrhoea—Dactinomycin—melanoma	0.000419	0.00198	CcSEcCtD
Trimethoprim—Vomiting—Bleomycin—melanoma	0.000417	0.00197	CcSEcCtD
Trimethoprim—Rash—Bleomycin—melanoma	0.000414	0.00195	CcSEcCtD
Trimethoprim—Dermatitis—Bleomycin—melanoma	0.000414	0.00195	CcSEcCtD
Trimethoprim—Hypersensitivity—Temozolomide—melanoma	0.000408	0.00192	CcSEcCtD
Trimethoprim—Syncope—Docetaxel—melanoma	0.000405	0.00191	CcSEcCtD
Trimethoprim—Leukopenia—Docetaxel—melanoma	0.000404	0.00191	CcSEcCtD
Trimethoprim—Loss of consciousness—Docetaxel—melanoma	0.000397	0.00187	CcSEcCtD
Trimethoprim—Cough—Docetaxel—melanoma	0.000394	0.00186	CcSEcCtD
Trimethoprim—Diarrhoea—Carmustine—melanoma	0.000392	0.00185	CcSEcCtD
Trimethoprim—Pruritus—Temozolomide—melanoma	0.000392	0.00185	CcSEcCtD
Trimethoprim—Convulsion—Docetaxel—melanoma	0.000391	0.00184	CcSEcCtD
Trimethoprim—Nausea—Bleomycin—melanoma	0.00039	0.00184	CcSEcCtD
Trimethoprim—Vomiting—Dactinomycin—melanoma	0.000389	0.00184	CcSEcCtD
Trimethoprim—Rash—Dactinomycin—melanoma	0.000386	0.00182	CcSEcCtD
Trimethoprim—Arthralgia—Docetaxel—melanoma	0.000384	0.00181	CcSEcCtD
Trimethoprim—Myalgia—Docetaxel—melanoma	0.000384	0.00181	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000382	0.0018	CcSEcCtD
Trimethoprim—Dizziness—Carmustine—melanoma	0.000379	0.00179	CcSEcCtD
Trimethoprim—Diarrhoea—Temozolomide—melanoma	0.000379	0.00179	CcSEcCtD
Trimethoprim—Confusional state—Docetaxel—melanoma	0.000371	0.00175	CcSEcCtD
Trimethoprim—Anaphylactic shock—Docetaxel—melanoma	0.000368	0.00174	CcSEcCtD
Trimethoprim—Dizziness—Temozolomide—melanoma	0.000366	0.00173	CcSEcCtD
Trimethoprim—Vomiting—Carmustine—melanoma	0.000364	0.00172	CcSEcCtD
Trimethoprim—Nausea—Dactinomycin—melanoma	0.000364	0.00172	CcSEcCtD
Trimethoprim—Shock—Docetaxel—melanoma	0.000362	0.00171	CcSEcCtD
Trimethoprim—Rash—Carmustine—melanoma	0.000361	0.0017	CcSEcCtD
Trimethoprim—Nervous system disorder—Docetaxel—melanoma	0.000361	0.0017	CcSEcCtD
Trimethoprim—Dermatitis—Carmustine—melanoma	0.000361	0.0017	CcSEcCtD
Trimethoprim—Thrombocytopenia—Docetaxel—melanoma	0.000361	0.0017	CcSEcCtD
Trimethoprim—Headache—Carmustine—melanoma	0.000359	0.00169	CcSEcCtD
Trimethoprim—Skin disorder—Docetaxel—melanoma	0.000358	0.00169	CcSEcCtD
Trimethoprim—Vomiting—Temozolomide—melanoma	0.000352	0.00166	CcSEcCtD
Trimethoprim—Anorexia—Docetaxel—melanoma	0.000351	0.00166	CcSEcCtD
Trimethoprim—Rash—Temozolomide—melanoma	0.000349	0.00165	CcSEcCtD
Trimethoprim—Dermatitis—Temozolomide—melanoma	0.000349	0.00165	CcSEcCtD
Trimethoprim—Headache—Temozolomide—melanoma	0.000347	0.00164	CcSEcCtD
Trimethoprim—Nausea—Carmustine—melanoma	0.00034	0.00161	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Docetaxel—melanoma	0.000336	0.00158	CcSEcCtD
Trimethoprim—Insomnia—Docetaxel—melanoma	0.000333	0.00157	CcSEcCtD
Trimethoprim—Nausea—Temozolomide—melanoma	0.000329	0.00155	CcSEcCtD
Trimethoprim—Dyspnoea—Docetaxel—melanoma	0.000328	0.00155	CcSEcCtD
Trimethoprim—Dyspepsia—Docetaxel—melanoma	0.000324	0.00153	CcSEcCtD
Trimethoprim—Decreased appetite—Docetaxel—melanoma	0.00032	0.00151	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Docetaxel—melanoma	0.000318	0.0015	CcSEcCtD
Trimethoprim—Constipation—Docetaxel—melanoma	0.000315	0.00149	CcSEcCtD
Trimethoprim—Feeling abnormal—Docetaxel—melanoma	0.000304	0.00143	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Docetaxel—melanoma	0.000301	0.00142	CcSEcCtD
Trimethoprim—Abdominal pain—Docetaxel—melanoma	0.000291	0.00137	CcSEcCtD
Trimethoprim—Body temperature increased—Docetaxel—melanoma	0.000291	0.00137	CcSEcCtD
Trimethoprim—Hypersensitivity—Docetaxel—melanoma	0.000271	0.00128	CcSEcCtD
Trimethoprim—Pruritus—Docetaxel—melanoma	0.000261	0.00123	CcSEcCtD
Trimethoprim—Diarrhoea—Docetaxel—melanoma	0.000252	0.00119	CcSEcCtD
Trimethoprim—Dizziness—Docetaxel—melanoma	0.000244	0.00115	CcSEcCtD
Trimethoprim—Vomiting—Docetaxel—melanoma	0.000234	0.0011	CcSEcCtD
Trimethoprim—Rash—Docetaxel—melanoma	0.000232	0.0011	CcSEcCtD
Trimethoprim—Dermatitis—Docetaxel—melanoma	0.000232	0.00109	CcSEcCtD
Trimethoprim—Headache—Docetaxel—melanoma	0.000231	0.00109	CcSEcCtD
Trimethoprim—Nausea—Docetaxel—melanoma	0.000219	0.00103	CcSEcCtD
Trimethoprim—DHFR—Metabolism—ABCB1—melanoma	4.97e-05	0.000349	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HIF1A—melanoma	4.85e-05	0.000341	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	4.83e-05	0.000339	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN1A—melanoma	4.83e-05	0.000339	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	4.75e-05	0.000334	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MAPK3—melanoma	4.71e-05	0.000331	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PLCB4—melanoma	4.68e-05	0.000329	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	4.63e-05	0.000325	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MAPK3—melanoma	4.6e-05	0.000323	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—FASN—melanoma	4.6e-05	0.000323	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	4.59e-05	0.000322	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYC—melanoma	4.59e-05	0.000322	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PRKCA—melanoma	4.57e-05	0.000321	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ERCC2—melanoma	4.53e-05	0.000319	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MAPK1—melanoma	4.49e-05	0.000315	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYC—melanoma	4.47e-05	0.000314	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NOS2—melanoma	4.41e-05	0.00031	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIP4K2A—melanoma	4.4e-05	0.000309	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC6A11—melanoma	4.4e-05	0.000309	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MAPK1—melanoma	4.38e-05	0.000308	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NOTCH1—melanoma	4.37e-05	0.000307	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	4.36e-05	0.000307	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ABCB1—melanoma	4.33e-05	0.000305	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CD80—melanoma	4.28e-05	0.000301	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—MTAP—melanoma	4.28e-05	0.000301	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KIT—melanoma	4.28e-05	0.0003	CbGpPWpGaD
Trimethoprim—DHFR—Disease—APC—melanoma	4.28e-05	0.0003	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGF—melanoma	4.23e-05	0.000297	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.19e-05	0.000294	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	4.14e-05	0.000291	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MAPK3—melanoma	4.11e-05	0.000289	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	4.08e-05	0.000287	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PLCB4—melanoma	4.08e-05	0.000287	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	4.05e-05	0.000284	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	4.02e-05	0.000283	CbGpPWpGaD
Trimethoprim—DHFR—Disease—BRAF—melanoma	4.02e-05	0.000282	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYC—melanoma	4e-05	0.000281	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PRKCA—melanoma	3.99e-05	0.00028	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ERCC2—melanoma	3.96e-05	0.000278	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	3.94e-05	0.000277	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MAPK1—melanoma	3.91e-05	0.000275	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ACER3—melanoma	3.9e-05	0.000274	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC6A11—melanoma	3.84e-05	0.00027	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIP4K2A—melanoma	3.84e-05	0.00027	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PHGDH—melanoma	3.82e-05	0.000268	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—LUM—melanoma	3.82e-05	0.000268	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PLCB4—melanoma	3.81e-05	0.000268	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MAP2K1—melanoma	3.78e-05	0.000266	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—melanoma	3.77e-05	0.000265	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CD—melanoma	3.76e-05	0.000264	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	3.74e-05	0.000263	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—HPSE—melanoma	3.74e-05	0.000263	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	3.74e-05	0.000263	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MTAP—melanoma	3.73e-05	0.000262	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	3.73e-05	0.000262	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CUBN—melanoma	3.67e-05	0.000258	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	3.65e-05	0.000257	CbGpPWpGaD
Trimethoprim—DHFR—Disease—FGF2—melanoma	3.6e-05	0.000253	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC6A11—melanoma	3.58e-05	0.000252	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIP4K2A—melanoma	3.58e-05	0.000252	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CG—melanoma	3.58e-05	0.000252	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—UGT2B10—melanoma	3.57e-05	0.000251	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	3.56e-05	0.00025	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SDHD—melanoma	3.55e-05	0.000249	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CSPG4—melanoma	3.55e-05	0.000249	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—BSG—melanoma	3.55e-05	0.000249	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	3.52e-05	0.000247	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MTAP—melanoma	3.49e-05	0.000245	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PPARG—melanoma	3.46e-05	0.000243	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	3.44e-05	0.000242	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GPAM—melanoma	3.44e-05	0.000242	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	3.43e-05	0.000241	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	3.42e-05	0.00024	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.41e-05	0.000239	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MDM2—melanoma	3.37e-05	0.000237	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—LUM—melanoma	3.33e-05	0.000234	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PHGDH—melanoma	3.33e-05	0.000234	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ERBB2—melanoma	3.32e-05	0.000233	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HS3ST5—melanoma	3.32e-05	0.000233	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—melanoma	3.29e-05	0.000231	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CB—melanoma	3.28e-05	0.00023	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CD4—melanoma	3.27e-05	0.00023	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—HPSE—melanoma	3.26e-05	0.000229	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTGS2—melanoma	3.25e-05	0.000228	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CUBN—melanoma	3.2e-05	0.000225	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CD—melanoma	3.15e-05	0.000221	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CG—melanoma	3.12e-05	0.00022	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ALB—melanoma	3.11e-05	0.000218	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—LUM—melanoma	3.11e-05	0.000218	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PHGDH—melanoma	3.11e-05	0.000218	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.1e-05	0.000218	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SDHD—melanoma	3.09e-05	0.000217	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—BSG—melanoma	3.09e-05	0.000217	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CSPG4—melanoma	3.09e-05	0.000217	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1B—melanoma	3.07e-05	0.000216	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—HPSE—melanoma	3.05e-05	0.000214	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PPARG—melanoma	3.02e-05	0.000212	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GPAM—melanoma	2.99e-05	0.00021	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CUBN—melanoma	2.99e-05	0.00021	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	2.93e-05	0.000206	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PLA2G6—melanoma	2.92e-05	0.000205	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CTNNB1—melanoma	2.9e-05	0.000204	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SDHD—melanoma	2.89e-05	0.000203	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—BSG—melanoma	2.89e-05	0.000203	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CSPG4—melanoma	2.89e-05	0.000203	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	2.85e-05	0.0002	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1A—melanoma	2.84e-05	0.000199	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTEN—melanoma	2.83e-05	0.000199	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GPAM—melanoma	2.8e-05	0.000197	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	2.79e-05	0.000196	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	2.79e-05	0.000196	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CD—melanoma	2.75e-05	0.000193	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CB—melanoma	2.74e-05	0.000193	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTGS2—melanoma	2.72e-05	0.000191	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ALB—melanoma	2.71e-05	0.000191	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.66e-05	0.000187	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.64e-05	0.000185	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—VCAN—melanoma	2.62e-05	0.000184	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PLA2G6—melanoma	2.55e-05	0.000179	CbGpPWpGaD
Trimethoprim—DHFR—Disease—STAT3—melanoma	2.53e-05	0.000178	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NRAS—melanoma	2.53e-05	0.000177	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PLCB4—melanoma	2.51e-05	0.000177	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.48e-05	0.000175	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.42e-05	0.00017	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MAPK3—melanoma	2.42e-05	0.00017	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.4e-05	0.000169	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CB—melanoma	2.39e-05	0.000168	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PLA2G6—melanoma	2.38e-05	0.000167	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS2—melanoma	2.37e-05	0.000167	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTEN—melanoma	2.37e-05	0.000167	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC6A11—melanoma	2.36e-05	0.000166	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIP4K2A—melanoma	2.36e-05	0.000166	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—melanoma	2.35e-05	0.000165	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.34e-05	0.000165	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MAPK1—melanoma	2.3e-05	0.000162	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGFR—melanoma	2.3e-05	0.000162	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTAP—melanoma	2.3e-05	0.000162	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—VCAN—melanoma	2.29e-05	0.000161	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP17A1—melanoma	2.21e-05	0.000156	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.18e-05	0.000153	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KRAS—melanoma	2.17e-05	0.000153	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	2.16e-05	0.000152	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—VCAN—melanoma	2.14e-05	0.00015	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GNA11—melanoma	2.09e-05	0.000147	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTEN—melanoma	2.07e-05	0.000145	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PHGDH—melanoma	2.05e-05	0.000144	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LUM—melanoma	2.05e-05	0.000144	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—FASN—melanoma	2.05e-05	0.000144	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.02e-05	0.000142	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC5A5—melanoma	2.01e-05	0.000141	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HPSE—melanoma	2.01e-05	0.000141	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CA—melanoma	2e-05	0.00014	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.98e-05	0.000139	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CUBN—melanoma	1.97e-05	0.000139	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.95e-05	0.000137	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GNAQ—melanoma	1.94e-05	0.000137	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CD44—melanoma	1.94e-05	0.000137	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP17A1—melanoma	1.93e-05	0.000136	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SDHD—melanoma	1.9e-05	0.000134	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CSPG4—melanoma	1.9e-05	0.000134	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—BSG—melanoma	1.9e-05	0.000134	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.9e-05	0.000134	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.89e-05	0.000133	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP1B1—melanoma	1.86e-05	0.000131	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HRAS—melanoma	1.85e-05	0.00013	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GPAM—melanoma	1.84e-05	0.00013	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GNA11—melanoma	1.82e-05	0.000128	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP17A1—melanoma	1.8e-05	0.000127	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.79e-05	0.000126	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—FASN—melanoma	1.78e-05	0.000125	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.78e-05	0.000125	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IL6—melanoma	1.77e-05	0.000124	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.75e-05	0.000123	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC5A5—melanoma	1.75e-05	0.000123	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GNA11—melanoma	1.7e-05	0.00012	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GNAQ—melanoma	1.69e-05	0.000119	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CD44—melanoma	1.69e-05	0.000119	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CA—melanoma	1.67e-05	0.000118	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—FASN—melanoma	1.67e-05	0.000117	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.65e-05	0.000116	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC5A5—melanoma	1.64e-05	0.000115	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT1—melanoma	1.63e-05	0.000115	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP1B1—melanoma	1.62e-05	0.000114	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GNAQ—melanoma	1.58e-05	0.000111	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CD44—melanoma	1.58e-05	0.000111	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PLA2G6—melanoma	1.57e-05	0.00011	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.55e-05	0.000109	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.54e-05	0.000108	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCB1—melanoma	1.53e-05	0.000108	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP1B1—melanoma	1.52e-05	0.000107	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CA—melanoma	1.46e-05	0.000103	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PRKCA—melanoma	1.41e-05	9.93e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—VCAN—melanoma	1.41e-05	9.9e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ERCC2—melanoma	1.4e-05	9.85e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKT1—melanoma	1.37e-05	9.6e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.34e-05	9.41e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCB1—melanoma	1.25e-05	8.78e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PRKCA—melanoma	1.23e-05	8.65e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ERCC2—melanoma	1.22e-05	8.58e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKT1—melanoma	1.19e-05	8.38e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP17A1—melanoma	1.19e-05	8.35e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.16e-05	8.16e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PRKCA—melanoma	1.15e-05	8.08e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ERCC2—melanoma	1.14e-05	8.01e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GNA11—melanoma	1.12e-05	7.89e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CG—melanoma	1.11e-05	7.78e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—FASN—melanoma	1.1e-05	7.72e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC5A5—melanoma	1.08e-05	7.59e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PPARG—melanoma	1.07e-05	7.5e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GNAQ—melanoma	1.04e-05	7.33e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CD44—melanoma	1.04e-05	7.33e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP1B1—melanoma	1e-05	7.03e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CD—melanoma	9.73e-06	6.84e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CG—melanoma	9.64e-06	6.77e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALB—melanoma	9.6e-06	6.75e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.45e-06	6.64e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PPARG—melanoma	9.3e-06	6.54e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CG—melanoma	9.01e-06	6.33e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PPARG—melanoma	8.69e-06	6.11e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CB—melanoma	8.48e-06	5.96e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CD—melanoma	8.47e-06	5.96e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS2—melanoma	8.4e-06	5.9e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALB—melanoma	8.37e-06	5.88e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCB1—melanoma	8.24e-06	5.79e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CD—melanoma	7.92e-06	5.56e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALB—melanoma	7.81e-06	5.49e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PRKCA—melanoma	7.58e-06	5.33e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ERCC2—melanoma	7.52e-06	5.28e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CB—melanoma	7.39e-06	5.19e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTEN—melanoma	7.33e-06	5.15e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS2—melanoma	7.32e-06	5.14e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CB—melanoma	6.9e-06	4.85e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS2—melanoma	6.84e-06	4.8e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTEN—melanoma	6.38e-06	4.49e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTEN—melanoma	5.96e-06	4.19e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CG—melanoma	5.94e-06	4.17e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPARG—melanoma	5.73e-06	4.03e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CD—melanoma	5.22e-06	3.67e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CA—melanoma	5.17e-06	3.63e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALB—melanoma	5.15e-06	3.62e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CB—melanoma	4.55e-06	3.2e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS2—melanoma	4.51e-06	3.17e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CA—melanoma	4.5e-06	3.16e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKT1—melanoma	4.22e-06	2.97e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CA—melanoma	4.21e-06	2.96e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTEN—melanoma	3.93e-06	2.76e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKT1—melanoma	3.68e-06	2.58e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKT1—melanoma	3.44e-06	2.41e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CA—melanoma	2.77e-06	1.95e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKT1—melanoma	2.27e-06	1.59e-05	CbGpPWpGaD
